SE0000514D0 - A 52 kDa protein from coagulase negative staphylococci and fragments - Google Patents

A 52 kDa protein from coagulase negative staphylococci and fragments

Info

Publication number
SE0000514D0
SE0000514D0 SE0000514A SE0000514A SE0000514D0 SE 0000514 D0 SE0000514 D0 SE 0000514D0 SE 0000514 A SE0000514 A SE 0000514A SE 0000514 A SE0000514 A SE 0000514A SE 0000514 D0 SE0000514 D0 SE 0000514D0
Authority
SE
Sweden
Prior art keywords
protein
fragments
antigen
antibodies
vector
Prior art date
Application number
SE0000514A
Other languages
English (en)
Inventor
Aasa Ljungh
Dai-Quing Li
Fredrik Lundberg
Original Assignee
Biostapro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostapro Ab filed Critical Biostapro Ab
Priority to SE0000514A priority Critical patent/SE0000514D0/sv
Publication of SE0000514D0 publication Critical patent/SE0000514D0/sv
Priority to EP01906475A priority patent/EP1261631A1/en
Priority to US10/203,613 priority patent/US20030082200A1/en
Priority to PCT/SE2001/000340 priority patent/WO2001060852A1/en
Priority to JP2001560235A priority patent/JP2003523191A/ja
Priority to AU2001234299A priority patent/AU2001234299A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
SE0000514A 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments SE0000514D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments
EP01906475A EP1261631A1 (en) 2000-02-17 2001-02-16 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
US10/203,613 US20030082200A1 (en) 2000-02-17 2001-02-16 52 kda protein from coagulase negative staphylococci and fragments thereof
PCT/SE2001/000340 WO2001060852A1 (en) 2000-02-17 2001-02-16 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
JP2001560235A JP2003523191A (ja) 2000-02-17 2001-02-16 コアグラーゼ陰性ブドウ球菌からの５２ｋＤａ蛋白質及びそのフラグメント
AU2001234299A AU2001234299A1 (en) 2000-02-17 2001-02-16 A 52 kda protein from coagulase negative staphylococci and fragments thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments

Publications (1)

Publication Number Publication Date
SE0000514D0 true SE0000514D0 (sv) 2000-02-17

Family

ID=20278484

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments

Country Status (6)

Country Link
US (1) US20030082200A1 (sv)
EP (1) EP1261631A1 (sv)
JP (1) JP2003523191A (sv)
AU (1) AU2001234299A1 (sv)
SE (1) SE0000514D0 (sv)
WO (1) WO2001060852A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
CA2580103C (en) 2004-09-22 2021-11-16 Glaxosmithkline Biologicals S.A. Immunogenic composition
EP1998802A2 (en) 2006-03-30 2008-12-10 GlaxoSmithKline Biologicals S.A. Immunogenic composition
CA2684570A1 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
KR101661946B1 (ko) 2007-08-31 2016-10-05 유니버시티 오브 시카고 스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
BRPI0920041A2 (pt) 2008-10-06 2017-06-27 Univ Chicago composições e processos relacionados às proteínas eap, emp e/ou adsa bacterianas
PL3281947T3 (pl) 2009-04-03 2020-07-27 The University Of Chicago Kompozycje i sposoby związane z wariantami białka A (SpA)
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
WO2012034067A1 (en) 2010-09-09 2012-03-15 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CN103906535B (zh) 2011-08-15 2017-07-14 芝加哥大学 与葡萄球菌蛋白a的抗体相关的组合物和方法
CN102952067A (zh) * 2011-08-30 2013-03-06 苏州欣诺科生物科技有限公司 用于蛋白质n端聚乙二醇修饰的吡哆醛衍生物、制备方法及其应用
NZ702282A (en) 2012-04-26 2016-07-29 Univ Chicago Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
DK2844275T3 (da) 2012-04-26 2020-07-13 Univ Chicago Staphylokok-koagulase-antigener og fremgangsmåder til anvendelse af disse
KR20220107166A (ko) 2019-10-02 2022-08-02 얀센 백신스 앤드 프리벤션 비.브이. 스타필로코커스 펩티드 및 사용 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402490D0 (sv) * 1994-07-15 1994-07-15 Jan Ingmar Flock Vitronection binding protein

Also Published As

Publication number Publication date
EP1261631A1 (en) 2002-12-04
WO2001060852A1 (en) 2001-08-23
US20030082200A1 (en) 2003-05-01
JP2003523191A (ja) 2003-08-05
AU2001234299A1 (en) 2001-08-27

Similar Documents

Publication Publication Date Title
SE0000514D0 (sv) A 52 kDa protein from coagulase negative staphylococci and fragments
JP2009520758A5 (sv)
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
HRP20161305T1 (hr) Liječenje mikrobnih infekcija
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
Ovchinnikov et al. Topology of Na+, K+-ATPase Identification of the extra-and intracellular hydrophilic loops of the catalytic subunit by specific antibodies
EA199800973A1 (ru) Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение
CA2450939A1 (en) Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CA2371714A1 (en) Streptococcus pneumoniae proteins and vaccines
DK1194560T3 (da) Antigene Neisseria-peptider
RU2001134170A (ru) Антигенные пептиды NEISSERIA
RU2005123050A (ru) Супер-антигенные фьюжн-белки и их использование
NO902251L (no) Fremstilling av gonoreiske p1-proteiner og vaksiner.
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
JP2002513802A5 (sv)
PT1417222E (pt) Polipéptidos isolados baseados no epítopo neutralizante da proteína p17 de vih, úteis como vacinas, e anticorpos antip17 neutralizantes que reconhecem especificamente o referido polipéptido neutralizante
EP1987836A1 (en) Protective staphylococcus aureus vaccine based on cell wall-associated proteins
JPWO2020071554A5 (sv)
CA2353802A1 (en) New protective antigen of group a streptococci
US20020081304A1 (en) Type f botulinum toxin and use thereof
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
EP1090995A3 (en) Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
CA2223503A1 (en) Transferrin receptor genes
RU2003129163A (ru) Полинуклеотид, который можно использовать для модулирования пролиферации раковых клеток
PL400683A1 (pl) Sekwencja DNA oraz sposób otrzymywania rekombinowanego alergenu pylku traw PHL P4